Loading...
Milan Laboratories (india) Private Limited — Clotrimazole Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #11 for Clotrimazole · $1.6M export value · DGFT Verified
Milan Laboratories (india) Private Limited is the #11 Indian exporter of Clotrimazole with $1.6M in export value and 82 verified shipments. Milan Laboratories (india) Private Limited holds a 1.7% market share in Clotrimazole exports across 2 countries. The company exports 5 pharmaceutical products worth $4.6M across 5 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $1.7M | 88 | 98.8% |
| NAMBIA | $15.1K | 5 | 0.9% |
| MYANMAR | $5.2K | 1 | 0.3% |
Milan Laboratories (india) Private Limited exports Clotrimazole to 3 countries. The largest destination is SOUTH AFRICA accounting for 98.8% of Milan Laboratories (india) Private Limited's Clotrimazole shipments, followed by NAMBIA (0.9%) and MYANMAR (0.3%). These destinations reflect Milan Laboratories (india) Private Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | SOUTH AFRICA | $557.4K | 34 |
| AUSTELL PHARMACEUTICALS (PTY) LTD. | SOUTH AFRICA | $234.0K | 7 |
| ASCENDIS PHARMA PTY LIMITED | SOUTH AFRICA | $197.1K | 8 |
| TO THE ORDER OF'' | SOUTH AFRICA | $135.8K | 6 |
| SHANUR HEALTHCARE (PTY) LTD | SOUTH AFRICA | $113.6K | 5 |
| TO THE ORDER OF""., | SOUTH AFRICA | $113.1K | 3 |
| ZIEGLER SOUTH AFRICA (PTY) LTD 136 | SOUTH AFRICA | $110.4K |
Milan Laboratories (india) Private Limited supplies Clotrimazole to 15 buyers globally. The largest buyer is TO THE ORDER (SOUTH AFRICA), followed by AUSTELL PHARMACEUTICALS (PTY) LTD. (SOUTH AFRICA) and ASCENDIS PHARMA PTY LIMITED (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $58.5M worth of Clotrimazole through 10,037 shipments from 712 suppliers to 158 countries, serving 1,728 buyers globally. Milan Laboratories (india) Private Limited contributes $1.6M to this total, accounting for 1.7% of India's Clotrimazole exports. Milan Laboratories (india) Private Limited ships Clotrimazole to 3 countries through 15 buyers.
Milan Laboratories (india) Private Limited's average Clotrimazole shipment value is $19.0K per consignment, based on 82 shipments totaling $1.6M. The largest destination is SOUTH AFRICA (98.8% of Milan Laboratories (india) Private Limited's Clotrimazole exports).
Milan Laboratories (india) Private Limited ranks #11 among 712 Indian Clotrimazole exporters with a 1.7% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($12.0M), ENCUBE ETHICALS PRIVATE LIMITED ($10.0M), S KANT HEALTHCARE LIMITED ($7.2M). Milan Laboratories (india) Private Limited processed 82 shipments to 2 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA.GOODS/HARMLESS MEDICINE: CANEX VCREAM (146096X1X50GM) EACH 1G CREAM CONTAINS 10 MG CLOTRIMAZOLE | $100.9K | 3 |
| PHARMA.GOODS/HARMLESS MEDICINE:CANEX V CREAM(145407X1X50GM)EACH 1G CREAM CONTAINS 10 MG CLOTRIMAZOLENOS | $100.3K | 3 |
| PHARMA.GOODS/HARMLESS MEDICINE: CANEX VCREAM [145473X1X50GM] EACH 1G CREAM CONTAINS 10 MG CLOTRIMAZOLE | $100.2K | 3 |
| PHARMA.GOODS/HARMLESS MEDICINE: XERASPORV 50G CREAM-CLICKS LABEL EACH[125909X1X50GM]GRAM OF CREAM CONT CLOTRIMAZOLE10MG | $79.7K | 3 |
| PHARMA.GOODS/HARMLESS MEDICINE:XERASPORV 50G CREAM-CLICKS LABEL[116365X1X50GM]EACH GRAM OF CREAM CONTAINS CLOTRIMAZOLENOS | $71.7K | 3 |
| PHARMA.GOODS/HARMLESS MEDICINE: CANEX VCREAM (77580X1X50GM) EACH 1G CREAM CONTAINS 10 MG CLOTRIMAZOLE | $53.6K | 3 |
| PHARMA. GOODS/HARMLESS MEDICINE:CANEX VCREAM95735x1X50GMEach 1g cream contains 10 mg clotrimazole | $50.0K |
What Milan Laboratories (india) Private Limited must comply with to export Clotrimazole to its top destination countries
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | KUSUM HEALTHCARE PRIVATE LIMITED | $2.0M | 142 | 13 | $14.0K |
| 10 | CIPLA LIMITED | $1.7M | 147 | 5 | $11.8K |
| 11 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED ★ | $1.6M | 82 | 2 | $19.0K |
| 12 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED |
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,379 | 13.7% |
| SAHAR AIR | 1,261 | 12.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,130 | 11.3% |
| JNPT/ NHAVA SHEVA SEA | 939 | 9.4% |
| JNPT | 636 | 6.3% |
| DELHI AIR CARGO ACC (INDEL4) | 517 | 5.2% |
| DELHI AIR | 380 | 3.8% |
| Bombay Air | 358 | 3.6% |
Milan Laboratories (india) Private Limited exports 5 products worth $4.6M. Beyond Clotrimazole, top products include Flucloxacillin, Rivaroxaban, Clonazepam, Quinine. View the complete Milan Laboratories (india) Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Clotrimazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Milan Laboratories (india) Private Limited's Clotrimazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Milan Laboratories (india) Private Limited
Full Company Profile →
5 products · $4.6M total trade · 5 categories
| 6 |
| FAIR DEAL CORPORATION SA (PTY) LIMITED | SOUTH AFRICA | $83.8K | 4 |
| ASCENDIS PHARMA (PTY) LIMITED | SOUTH AFRICA | $66.1K | 9 |
| ASCENDIS PHARMA (PTY) LTD | SOUTH AFRICA | $58.5K | 3 |
| 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:CANEX T CREAM EACH 1G CREAM CONTAINS 10MG CLOTRIMAZOLE [193834X1X20GM] | $50.0K | 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:CANEX V CREAM[77433x1x50GM]Each 1g cream contains10 mg clotrimazole | $50.0K | 1 |
| PHARMA.GOODS/HARMLESS MEDICINE:CANEX V CREAM[77623x1x50GM]Each 1g cream contains10 mg clotrimazole | $50.0K | 1 |
Milan Laboratories (india) Private Limited exports 58 distinct Clotrimazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA.GOODS/HARMLESS MEDICINE: CANEX VCREAM (146096X1X50GM) with 3 shipments worth $100.9K.
| $1.5M |
| 98 |
| 16 |
| $14.8K |
| 13 | AGIO PHARMACEUTICALS LIMITED | $1.4M | 136 | 9 | $10.3K |
Milan Laboratories (india) Private Limited ranks #11 among 712 Indian Clotrimazole exporters. Average shipment value of $19.0K compared to the market average of $82.1K. The closest competitors by value are KUSUM HEALTHCARE PRIVATE LIMITED and CIPLA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 158+ countries, 1,728+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Milan Laboratories (india) Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clotrimazole. For current shipment-level data, contact TransData Nexus.